G. Nováková et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
5
Table 3
Henry reaction of nitromethane with 2-methoxybenzaldehyde catalyzed by immobilized catalyst 4a and 4b
O
OH
NO2
CH3NO2; iPrOH
H
4a or 4b (5 mol %)
OCH3
OCH3
Cat. Cycle
4a
4b
Yielda (%)
eeb (%)
Yielda (%)
eeb (%)
1st
97
97
92
92
55
84
76
74
64
63
60
58
48
58
62
50
96
92
85
80
59
86
71
70
À59
À51
À48
À45
À42
À40
À37
À38
2nd
3rd
4th
5th
1stc
2ndc
3rdc
a
b
c
Reaction conditions: aldehyde: 0.5 mmol; nitromethane: 0.5 mL; catalyst: 5 mol %; temperature: 6 °C; solvent: iPrOH (1 mL); reaction time: 6 days.
The enantiomeric excess determined by HPLC using Chiralcel OD-H.
The reactions were performed under argon atmosphere with the catalysts prepared under inert conditions.
4.2. Synthesis
J = 3.2 Hz, Py), 8.26 (d, 1H, J = 8.0 Hz, Py), 8.00 (m, 1H, Py), 7.60
(m, 1H, Py), 2.20 (sp, 1H, J = 6.8 Hz, CH-iPr), 1.44 (s, 3H, Me), 1.17
(d, 3H, J = 6.8 Hz, CH3-iPr), 0.67 (d, 3H, J = 6.8 Hz, CH3-iPr); 13C
NMR (100 MHz, MeOD-d4): d 222.9, 161.7, 150.9, 147.6, 138.7,
127.7, 123.5, 90.2, 39.0, 25.7, 17.5, 16.9; Anal. Calcd for
4.2.1. 5-Isopropyl-5-methyl-2-(pyridine-2-yl)imidazolidine-4-
thiones 1a and 1b
A solution of (S)-amino-2,3-dimethylbutanethioamide (439 mg;
3 mmol), pyridine-2-carbaldehyde (482 mg; 4.5 mmol) and three
drops of acetic acid in n-butanol was stirred at 100 °C for 5 h.
The solvent was evaporated under reduced pressure and the resi-
due was treated with CH2Cl2 (10 mL). The mixture was washed
with a saturated aqueous solution of NaKCO3 (10 mL) and the
organic layer was dried over Na2SO4. After evaporation of solvent,
a mixture of diastereomers 1a–b and an oxidized form 1c was
separated by column chromatography [SiO2/acetone/CH2Cl2 (1:3),
(v/v)].
C12H15N3S (233.33): C, 61.77; H, 6.48; N, 18.01; S, 13.74. Found:
C, 61.63; H, 6.71; N, 17.86; S, 13.47. HR-MALDI-MS (DHB): calcd
for C12H15N3S m/z 234.10147 ([M+H]+), found 234.10594.
4.2.2. 4-Benzylsulfanyl-5-isopropyl-5-methyl-2-(pyridine-2-yl)
imidazolines 2a and 2b
A
solution of imidazolidine-4-thione derivative 1a or 1b
(180 mg; 0.81 mmol), benzyl bromide (138 mg; 0.81 mmol) and
DBU (246 mg; 1.62 mmol) in methanol (3 mL) was stirred at room
temperature for 5 days under an argon atmosphere. After evapora-
tion of the solvent under reduced pressure, the crude product was
purified by column chromatography [SiO2/n-hexane/AcOEt (1:2),
(v/v)].
4.2.1.1. (2R,5S)-5-Isopropyl-5-methyl-2-(pyridine-2-yl)imidazo-
20
lidine-4-thione 1a.
Yield: 47%; yellow oil; Rf 0.51; [
a]
=
D
+10.5 (c 0.90, CH3OH); 1H NMR (400 MHz, MeOD-d4): d 8.59 (d,
1H, J = 4.8 Hz, Py), 7.88 (m, 1H, Py), 7.54 (d, 1H, J = 8.0 Hz, Py),
7.41 (m, 1H, Py), 5.65 (s, 1H, NCHN), 2.17 (sp, 1H, J = 6.8 Hz, CH-
iPr), 1.44 (s, 3H, Me), 1.05 (d, 3H, J = 6.8 Hz, CH3-iPr), 1.01 (d, 3H,
4.2.2.1. (2R,5S)-4-Benzylsulfanyl-5-isopropyl-5-methyl-2-(pyri-
dine-2-yl)imidazoline 2a.
Yield: 84%; yellow oil; Rf 0.47
J = 6.8 Hz, CH3-iPr); 13C NMR (100 MHz, MeOD-d4):
d
210.9,
[a
]
D
20 = À13.8 (c 0.80, CH3OH); 1H NMR (400 MHz, MeOD-d4): d
158.6, 150.5, 139.0, 125.5, 123.6, 79.6, 78.0, 38.0, 27.2, 18.1, 16.8;
Anal. Calcd for C12H17N3S (235.35): C, 61.24; H, 7.28; N, 17.85; S,
13.62. Found: C, 61.56; H, 7.54; N, 17.62; S, 13.28. HR-MALDI-MS
(DHB): calcd for
236.12177.
8.55 (d, 1H, J = 4.8 Hz, Py), 7.83 (m, 1H, Py), 7.47 (d, 1H,
J = 8.0 Hz, Py), 7.37 (m, 3H, Py+Ph), 7.24 (m, 3H, Ph), 5.83 (s, 1H,
NCHN), 4.28 (2Â d, 2H, J = 13.2 Hz, CH2Ph), 1.85 (sp, 1H,
J = 6.8 Hz, CH-iPr), 1.38 (s, 3H, Me), 1.01 (d, 3H, J = 6.8 Hz,
CH3-iPr), 0.92 (d, 3H, J = 6.8 Hz, CH3-iPr); 13C NMR (100 MHz,
MeOD-d4): d 180.1, 160.5, 149.8, 138.7, 138.6, 130.1, 129.5,
128.4, 124.7, 123.8, 91.5, 78.8, 37.3, 36.1, 25.6, 18.0, 17.0; Anal.
Calcd for C19H23N3S (325.47): C, 70.12; H, 7.12; N, 12.91; S, 9.85.
Found: C, 69.94; H, 7.32; N, 12.63; S, 9.55. HR-MALDI-MS (DHB):
calcd for C19H23N3S m/z 326.16854 ([M+H]+), found 326.16922.
C
12H17N3S m/z 236.12159 ([M+H]+), found
4.2.1.2. (2S,5S)-5-Isopropyl-5-methyl-2-(pyridine-2-yl)imidazo-
lidine-4-thione 1b.
Yield: 34%; yellow oil; Rf 0.40;
[
a]
D
20 = À58.0 (c 0.70, CH3OH); 1H NMR (400 MHz, MeOD-d4): d
8.59 (d, 1H, J = 4.8 Hz, Py), 7.89 (m, 1H, Py), 7.61 (d, 1H,
J = 8.0 Hz, Py), 7.42 (m, 1H, Py), 5.72 (s, 1H, NCHN), 2.33 (sp, 1H,
J = 6.8 Hz, CH-iPr), 1.40 (s, 3H, Me), 1.03 (d, 3H, J = 6.8 Hz,
CH3-iPr), 0.97 (d, 3H, J = 6.8 Hz, CH3-iPr); 13C NMR (100 MHz,
MeOD-d4): d 210.9, 158.0, 150.3, 138.9, 125.6, 123.8, 77.4, 77.0,
35.8, 24.8, 18.3, 17.0; Anal. Calcd for C12H17N3S (235.35): C,
61.24; H, 7.28; N, 17.85; S, 13.62. Found: C, 61.09; H, 7.34; N,
17.72; S, 13.61 HR-MALDI-MS (DHB): calcd for C12H17N3S m/z
236.12159 ([M+H]+), found 236.12164.
4.2.2.2. (2S,5S)-4-Benzylsulfanyl-5-isopropyl-5-methyl-2-(pyri-
dine-2-yl)imidazoline 2b.
Yield: 69%; yellow oil; Rf 0.28
[a
]
D
20 = À19.6 (c 0.63, CH3OH); 1H NMR (400 MHz, MeOD-d4): d
8.55 (d, 1H, J = 4.9 Hz, Py), 7.86 (m, 1H, Py), 7.57 (d, 1H,
J = 7.6 Hz, Py), 7.40–7.32 (m, 3H, Py+Ph), 7.29–7.21 (m, 3H, Ph),
5.86 (s, 1H, NCHN), 4.29 (2Â d, 2H, J = 13.2 Hz, CH2Ph), 1.96 (sp,
1H, J = 6.8 Hz, CH-iPr), 1.34 (s, 3H, Me), 1.02 (d, 3H, J = 6.8 Hz,
CH3-iPr), 0.89 (d, 3H, J = 6.8 Hz, CH3-iPr); 13C NMR (100 MHz,
MeOD-d4): d 180.7, 160.1, 149.9, 138.7, 138.7, 130.2, 129.6,
128.5, 124.9, 124.3, 88.7, 78.4, 36.2, 35.2, 24.0, 18.6, 17.5; Anal.
Calcd for C19H23N3S (325.47): C, 70.12; H, 7.12; N, 12.91; S, 9.85.
4.2.1.3. (S)-5-Isopropyl-5-methyl-2-(pyridine-2-yl)imidazoline-
4-thione 1c.
Yield: 16%; yellow oil; Rf 0.63; [
a]
20 = À53.3 (c
D
0.70, CH3OH); 1H NMR (400 MHz, MeOD-d4): d 8.74 (d, 1H,